NCT05089643 2022-01-10
Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
Clinical Trials
6 trialsNCT01917279 2020-07-23
CAMELLIA
ChineseAMS
Phase 3 Unknown
NCT03923166 2019-04-22
Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT02947061 2016-10-31
S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01928680 2015-02-23
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01126138 2011-05-04
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
ChineseAMS
Phase 3 Unknown